The global market for Osteoarthritis Cell Therapy was valued at US$ 243 million in the year 2023 and is projected to reach a revised size of US$ 1631 million by 2030, growing at a CAGR of 30.3% during the forecast period.

Osteoarthritis Cell Therapy Market

Osteoarthritis Cell Therapy is an innovative treatment approach for osteoarthritis. It primarily involves the use of specific cells such as chondrocytes and mesenchymal stem cells. These cells are usually obtained from the patient's own joint cartilage, bone marrow, or adipose tissue, and then cultured, expanded, or induced to differentiate in vitro. Subsequently, they are implanted into the joint through intra - articular injection or tissue - engineered transplantation.

North American market for Osteoarthritis Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Osteoarthritis Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Osteoarthritis Cell Therapy in Primary Osteoarthritis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Osteoarthritis Cell Therapy include Vericel, Medi-post, Zimmer Biomet, Japan Tissue Engineering, Orthocell, Cambium Bio, CO.DON GmbH, Regrow Biosciences, Theracell Advanced Biotechnology, Nature Cell, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Osteoarthritis Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoarthritis Cell Therapy.

The Osteoarthritis Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Osteoarthritis Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Osteoarthritis Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Osteoarthritis Cell Therapy Market Report

Report Metric	Details
Report Name	Osteoarthritis Cell Therapy Market
Accounted market size in year	US$ 243 million
Forecasted market size in 2030	US$ 1631 million
CAGR	30.3%
Base Year	year
Forecasted years	2024 - 2030
Segment by Type	Chondrocytes Mesenchymal Stem Cells Others
Segment by Application	Primary Osteoarthritis Secondary Osteoarthritis
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Vericel, Medi-post, Zimmer Biomet, Japan Tissue Engineering, Orthocell, Cambium Bio, CO.DON GmbH, Regrow Biosciences, Theracell Advanced Biotechnology, Nature Cell, Stempeutics, Xintela AB, Cells for Cells, CellTex Therapeutics, UCI Health, Magellan, AbelZeta Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Osteoarthritis Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Osteoarthritis Cell Therapy Market growing?

Ans: The Osteoarthritis Cell Therapy Market witnessing a CAGR of 30.3% during the forecast period 2024-2030.

What is the Osteoarthritis Cell Therapy Market size in 2030?

Ans: The Osteoarthritis Cell Therapy Market size in 2030 will be US$ 1631 million.

Who are the main players in the Osteoarthritis Cell Therapy Market report?

Ans: The main players in the Osteoarthritis Cell Therapy Market are Vericel, Medi-post, Zimmer Biomet, Japan Tissue Engineering, Orthocell, Cambium Bio, CO.DON GmbH, Regrow Biosciences, Theracell Advanced Biotechnology, Nature Cell, Stempeutics, Xintela AB, Cells for Cells, CellTex Therapeutics, UCI Health, Magellan, AbelZeta Pharma

What are the Application segmentation covered in the Osteoarthritis Cell Therapy Market report?

Ans: The Applications covered in the Osteoarthritis Cell Therapy Market report are Primary Osteoarthritis, Secondary Osteoarthritis

What are the Type segmentation covered in the Osteoarthritis Cell Therapy Market report?

Ans: The Types covered in the Osteoarthritis Cell Therapy Market report are Chondrocytes, Mesenchymal Stem Cells, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Osteoarthritis Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Chondrocytes

1.2.3 Mesenchymal Stem Cells

1.2.4 Others

1.3 Market by Application

1.3.1 Global Osteoarthritis Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Primary Osteoarthritis

1.3.3 Secondary Osteoarthritis

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Osteoarthritis Cell Therapy Market Perspective (2019-2030)

2.2 Global Osteoarthritis Cell Therapy Growth Trends by Region

2.2.1 Global Osteoarthritis Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Osteoarthritis Cell Therapy Historic Market Size by Region (2019-2024)

2.2.3 Osteoarthritis Cell Therapy Forecasted Market Size by Region (2025-2030)

2.3 Osteoarthritis Cell Therapy Market Dynamics

2.3.1 Osteoarthritis Cell Therapy Industry Trends

2.3.2 Osteoarthritis Cell Therapy Market Drivers

2.3.3 Osteoarthritis Cell Therapy Market Challenges

2.3.4 Osteoarthritis Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Osteoarthritis Cell Therapy Players by Revenue

3.1.1 Global Top Osteoarthritis Cell Therapy Players by Revenue (2019-2024)

3.1.2 Global Osteoarthritis Cell Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Osteoarthritis Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Osteoarthritis Cell Therapy Revenue

3.4 Global Osteoarthritis Cell Therapy Market Concentration Ratio

3.4.1 Global Osteoarthritis Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Cell Therapy Revenue in 2023

3.5 Global Key Players of Osteoarthritis Cell Therapy Head office and Area Served

3.6 Global Key Players of Osteoarthritis Cell Therapy, Product and Application

3.7 Global Key Players of Osteoarthritis Cell Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Osteoarthritis Cell Therapy Breakdown Data by Type

4.1 Global Osteoarthritis Cell Therapy Historic Market Size by Type (2019-2024)

4.2 Global Osteoarthritis Cell Therapy Forecasted Market Size by Type (2025-2030)

5 Osteoarthritis Cell Therapy Breakdown Data by Application

5.1 Global Osteoarthritis Cell Therapy Historic Market Size by Application (2019-2024)

5.2 Global Osteoarthritis Cell Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Osteoarthritis Cell Therapy Market Size (2019-2030)

6.2 North America Osteoarthritis Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Osteoarthritis Cell Therapy Market Size by Country (2019-2024)

6.4 North America Osteoarthritis Cell Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Osteoarthritis Cell Therapy Market Size (2019-2030)

7.2 Europe Osteoarthritis Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Osteoarthritis Cell Therapy Market Size by Country (2019-2024)

7.4 Europe Osteoarthritis Cell Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Osteoarthritis Cell Therapy Market Size (2019-2030)

8.2 Asia-Pacific Osteoarthritis Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Osteoarthritis Cell Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Osteoarthritis Cell Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Osteoarthritis Cell Therapy Market Size (2019-2030)

9.2 Latin America Osteoarthritis Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Osteoarthritis Cell Therapy Market Size by Country (2019-2024)

9.4 Latin America Osteoarthritis Cell Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Osteoarthritis Cell Therapy Market Size (2019-2030)

10.2 Middle East & Africa Osteoarthritis Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Osteoarthritis Cell Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Osteoarthritis Cell Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Vericel

11.1.1 Vericel Company Details

11.1.2 Vericel Business Overview

11.1.3 Vericel Osteoarthritis Cell Therapy Introduction

11.1.4 Vericel Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.1.5 Vericel Recent Development

11.2 Medi-post

11.2.1 Medi-post Company Details

11.2.2 Medi-post Business Overview

11.2.3 Medi-post Osteoarthritis Cell Therapy Introduction

11.2.4 Medi-post Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.2.5 Medi-post Recent Development

11.3 Zimmer Biomet

11.3.1 Zimmer Biomet Company Details

11.3.2 Zimmer Biomet Business Overview

11.3.3 Zimmer Biomet Osteoarthritis Cell Therapy Introduction

11.3.4 Zimmer Biomet Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.3.5 Zimmer Biomet Recent Development

11.4 Japan Tissue Engineering

11.4.1 Japan Tissue Engineering Company Details

11.4.2 Japan Tissue Engineering Business Overview

11.4.3 Japan Tissue Engineering Osteoarthritis Cell Therapy Introduction

11.4.4 Japan Tissue Engineering Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.4.5 Japan Tissue Engineering Recent Development

11.5 Orthocell

11.5.1 Orthocell Company Details

11.5.2 Orthocell Business Overview

11.5.3 Orthocell Osteoarthritis Cell Therapy Introduction

11.5.4 Orthocell Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.5.5 Orthocell Recent Development

11.6 Cambium Bio

11.6.1 Cambium Bio Company Details

11.6.2 Cambium Bio Business Overview

11.6.3 Cambium Bio Osteoarthritis Cell Therapy Introduction

11.6.4 Cambium Bio Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.6.5 Cambium Bio Recent Development

11.7 CO.DON GmbH

11.7.1 CO.DON GmbH Company Details

11.7.2 CO.DON GmbH Business Overview

11.7.3 CO.DON GmbH Osteoarthritis Cell Therapy Introduction

11.7.4 CO.DON GmbH Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.7.5 CO.DON GmbH Recent Development

11.8 Regrow Biosciences

11.8.1 Regrow Biosciences Company Details

11.8.2 Regrow Biosciences Business Overview

11.8.3 Regrow Biosciences Osteoarthritis Cell Therapy Introduction

11.8.4 Regrow Biosciences Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.8.5 Regrow Biosciences Recent Development

11.9 Theracell Advanced Biotechnology

11.9.1 Theracell Advanced Biotechnology Company Details

11.9.2 Theracell Advanced Biotechnology Business Overview

11.9.3 Theracell Advanced Biotechnology Osteoarthritis Cell Therapy Introduction

11.9.4 Theracell Advanced Biotechnology Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.9.5 Theracell Advanced Biotechnology Recent Development

11.10 Nature Cell

11.10.1 Nature Cell Company Details

11.10.2 Nature Cell Business Overview

11.10.3 Nature Cell Osteoarthritis Cell Therapy Introduction

11.10.4 Nature Cell Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.10.5 Nature Cell Recent Development

11.11 Stempeutics

11.11.1 Stempeutics Company Details

11.11.2 Stempeutics Business Overview

11.11.3 Stempeutics Osteoarthritis Cell Therapy Introduction

11.11.4 Stempeutics Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.11.5 Stempeutics Recent Development

11.12 Xintela AB

11.12.1 Xintela AB Company Details

11.12.2 Xintela AB Business Overview

11.12.3 Xintela AB Osteoarthritis Cell Therapy Introduction

11.12.4 Xintela AB Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.12.5 Xintela AB Recent Development

11.13 Cells for Cells

11.13.1 Cells for Cells Company Details

11.13.2 Cells for Cells Business Overview

11.13.3 Cells for Cells Osteoarthritis Cell Therapy Introduction

11.13.4 Cells for Cells Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.13.5 Cells for Cells Recent Development

11.14 CellTex Therapeutics

11.14.1 CellTex Therapeutics Company Details

11.14.2 CellTex Therapeutics Business Overview

11.14.3 CellTex Therapeutics Osteoarthritis Cell Therapy Introduction

11.14.4 CellTex Therapeutics Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.14.5 CellTex Therapeutics Recent Development

11.15 UCI Health

11.15.1 UCI Health Company Details

11.15.2 UCI Health Business Overview

11.15.3 UCI Health Osteoarthritis Cell Therapy Introduction

11.15.4 UCI Health Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.15.5 UCI Health Recent Development

11.16 Magellan

11.16.1 Magellan Company Details

11.16.2 Magellan Business Overview

11.16.3 Magellan Osteoarthritis Cell Therapy Introduction

11.16.4 Magellan Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.16.5 Magellan Recent Development

11.17 AbelZeta Pharma

11.17.1 AbelZeta Pharma Company Details

11.17.2 AbelZeta Pharma Business Overview

11.17.3 AbelZeta Pharma Osteoarthritis Cell Therapy Introduction

11.17.4 AbelZeta Pharma Revenue in Osteoarthritis Cell Therapy Business (2019-2024)

11.17.5 AbelZeta Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Vericel

Medi post

Zimmer Biomet

Japan Tissue Engineering

Orthocell

Theracell Advanced Biotechnology

List of Tables

Table 1. Global Osteoarthritis Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Chondrocytes

Table 3. Key Players of Mesenchymal Stem Cells

Table 4. Key Players of Others

Table 5. Global Osteoarthritis Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Osteoarthritis Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Osteoarthritis Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Osteoarthritis Cell Therapy Market Share by Region (2019-2024)

Table 9. Global Osteoarthritis Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Osteoarthritis Cell Therapy Market Share by Region (2025-2030)

Table 11. Osteoarthritis Cell Therapy Market Trends

Table 12. Osteoarthritis Cell Therapy Market Drivers

Table 13. Osteoarthritis Cell Therapy Market Challenges

Table 14. Osteoarthritis Cell Therapy Market Restraints

Table 15. Global Osteoarthritis Cell Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Osteoarthritis Cell Therapy Market Share by Players (2019-2024)

Table 17. Global Top Osteoarthritis Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Cell Therapy as of 2023)

Table 18. Ranking of Global Top Osteoarthritis Cell Therapy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Osteoarthritis Cell Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Osteoarthritis Cell Therapy, Headquarters and Area Served

Table 21. Global Key Players of Osteoarthritis Cell Therapy, Product and Application

Table 22. Global Key Players of Osteoarthritis Cell Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Osteoarthritis Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Osteoarthritis Cell Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Osteoarthritis Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Osteoarthritis Cell Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Osteoarthritis Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Osteoarthritis Cell Therapy Revenue Market Share by Application (2019-2024)

Table 30. Global Osteoarthritis Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Osteoarthritis Cell Therapy Revenue Market Share by Application (2025-2030)

Table 32. North America Osteoarthritis Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Osteoarthritis Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Osteoarthritis Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Osteoarthritis Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Osteoarthritis Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Osteoarthritis Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Osteoarthritis Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Osteoarthritis Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Osteoarthritis Cell Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Osteoarthritis Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Osteoarthritis Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Osteoarthritis Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Osteoarthritis Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Osteoarthritis Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Osteoarthritis Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 47. Vericel Company Details

Table 48. Vericel Business Overview

Table 49. Vericel Osteoarthritis Cell Therapy Product

Table 50. Vericel Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 51. Vericel Recent Development

Table 52. Medi-post Company Details

Table 53. Medi-post Business Overview

Table 54. Medi-post Osteoarthritis Cell Therapy Product

Table 55. Medi-post Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 56. Medi-post Recent Development

Table 57. Zimmer Biomet Company Details

Table 58. Zimmer Biomet Business Overview

Table 59. Zimmer Biomet Osteoarthritis Cell Therapy Product

Table 60. Zimmer Biomet Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 61. Zimmer Biomet Recent Development

Table 62. Japan Tissue Engineering Company Details

Table 63. Japan Tissue Engineering Business Overview

Table 64. Japan Tissue Engineering Osteoarthritis Cell Therapy Product

Table 65. Japan Tissue Engineering Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 66. Japan Tissue Engineering Recent Development

Table 67. Orthocell Company Details

Table 68. Orthocell Business Overview

Table 69. Orthocell Osteoarthritis Cell Therapy Product

Table 70. Orthocell Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 71. Orthocell Recent Development

Table 72. Cambium Bio Company Details

Table 73. Cambium Bio Business Overview

Table 74. Cambium Bio Osteoarthritis Cell Therapy Product

Table 75. Cambium Bio Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 76. Cambium Bio Recent Development

Table 77. CO.DON GmbH Company Details

Table 78. CO.DON GmbH Business Overview

Table 79. CO.DON GmbH Osteoarthritis Cell Therapy Product

Table 80. CO.DON GmbH Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 81. CO.DON GmbH Recent Development

Table 82. Regrow Biosciences Company Details

Table 83. Regrow Biosciences Business Overview

Table 84. Regrow Biosciences Osteoarthritis Cell Therapy Product

Table 85. Regrow Biosciences Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 86. Regrow Biosciences Recent Development

Table 87. Theracell Advanced Biotechnology Company Details

Table 88. Theracell Advanced Biotechnology Business Overview

Table 89. Theracell Advanced Biotechnology Osteoarthritis Cell Therapy Product

Table 90. Theracell Advanced Biotechnology Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 91. Theracell Advanced Biotechnology Recent Development

Table 92. Nature Cell Company Details

Table 93. Nature Cell Business Overview

Table 94. Nature Cell Osteoarthritis Cell Therapy Product

Table 95. Nature Cell Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 96. Nature Cell Recent Development

Table 97. Stempeutics Company Details

Table 98. Stempeutics Business Overview

Table 99. Stempeutics Osteoarthritis Cell Therapy Product

Table 100. Stempeutics Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 101. Stempeutics Recent Development

Table 102. Xintela AB Company Details

Table 103. Xintela AB Business Overview

Table 104. Xintela AB Osteoarthritis Cell Therapy Product

Table 105. Xintela AB Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 106. Xintela AB Recent Development

Table 107. Cells for Cells Company Details

Table 108. Cells for Cells Business Overview

Table 109. Cells for Cells Osteoarthritis Cell Therapy Product

Table 110. Cells for Cells Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 111. Cells for Cells Recent Development

Table 112. CellTex Therapeutics Company Details

Table 113. CellTex Therapeutics Business Overview

Table 114. CellTex Therapeutics Osteoarthritis Cell Therapy Product

Table 115. CellTex Therapeutics Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 116. CellTex Therapeutics Recent Development

Table 117. UCI Health Company Details

Table 118. UCI Health Business Overview

Table 119. UCI Health Osteoarthritis Cell Therapy Product

Table 120. UCI Health Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 121. UCI Health Recent Development

Table 122. Magellan Company Details

Table 123. Magellan Business Overview

Table 124. Magellan Osteoarthritis Cell Therapy Product

Table 125. Magellan Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 126. Magellan Recent Development

Table 127. AbelZeta Pharma Company Details

Table 128. AbelZeta Pharma Business Overview

Table 129. AbelZeta Pharma Osteoarthritis Cell Therapy Product

Table 130. AbelZeta Pharma Revenue in Osteoarthritis Cell Therapy Business (2019-2024) & (US$ Million)

Table 131. AbelZeta Pharma Recent Development

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

Table 135. Authors List of This Report

List of Figures

Figure 1. Osteoarthritis Cell Therapy Picture

Figure 2. Global Osteoarthritis Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Osteoarthritis Cell Therapy Market Share by Type: 2023 VS 2030

Figure 4. Chondrocytes Features

Figure 5. Mesenchymal Stem Cells Features

Figure 6. Others Features

Figure 7. Global Osteoarthritis Cell Therapy Market Size by Application (2024-2030) & (US$ Million)

Figure 8. Global Osteoarthritis Cell Therapy Market Share by Application: 2023 VS 2030

Figure 9. Primary Osteoarthritis Case Studies

Figure 10. Secondary Osteoarthritis Case Studies

Figure 11. Osteoarthritis Cell Therapy Report Years Considered

Figure 12. Global Osteoarthritis Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Osteoarthritis Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Osteoarthritis Cell Therapy Market Share by Region: 2023 VS 2030

Figure 15. Global Osteoarthritis Cell Therapy Market Share by Players in 2023

Figure 16. Global Top Osteoarthritis Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Cell Therapy as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Osteoarthritis Cell Therapy Revenue in 2023

Figure 18. North America Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Osteoarthritis Cell Therapy Market Share by Country (2019-2030)

Figure 20. United States Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Osteoarthritis Cell Therapy Market Share by Country (2019-2030)

Figure 24. Germany Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Osteoarthritis Cell Therapy Market Share by Region (2019-2030)

Figure 32. China Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Osteoarthritis Cell Therapy Market Share by Country (2019-2030)

Figure 40. Mexico Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Osteoarthritis Cell Therapy Market Share by Country (2019-2030)

Figure 44. Turkey Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. UAE Osteoarthritis Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Vericel Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 48. Medi-post Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 49. Zimmer Biomet Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 50. Japan Tissue Engineering Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 51. Orthocell Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 52. Cambium Bio Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 53. CO.DON GmbH Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 54. Regrow Biosciences Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 55. Theracell Advanced Biotechnology Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 56. Nature Cell Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 57. Stempeutics Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 58. Xintela AB Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 59. Cells for Cells Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 60. CellTex Therapeutics Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 61. UCI Health Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 62. Magellan Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 63. AbelZeta Pharma Revenue Growth Rate in Osteoarthritis Cell Therapy Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions